U.S. markets closed
  • S&P 500

    4,326.51
    -23.42 (-0.54%)
     
  • Dow 30

    34,160.78
    -7.31 (-0.02%)
     
  • Nasdaq

    13,352.78
    -189.34 (-1.40%)
     
  • Russell 2000

    1,931.29
    -45.18 (-2.29%)
     
  • Crude Oil

    87.04
    -0.31 (-0.35%)
     
  • Gold

    1,794.90
    -34.80 (-1.90%)
     
  • Silver

    22.75
    -1.06 (-4.46%)
     
  • EUR/USD

    1.1146
    -0.0099 (-0.88%)
     
  • 10-Yr Bond

    1.8070
    -0.0410 (-2.22%)
     
  • GBP/USD

    1.3380
    -0.0082 (-0.61%)
     
  • USD/JPY

    115.3530
    +0.6930 (+0.60%)
     
  • BTC-USD

    35,802.33
    -1,066.40 (-2.89%)
     
  • CMC Crypto 200

    810.95
    -8.56 (-1.04%)
     
  • FTSE 100

    7,554.31
    +84.53 (+1.13%)
     
  • Nikkei 225

    26,170.30
    -841.03 (-3.11%)
     

Why Amarin Stock Tumbled in November

·2 min read
Why Amarin Stock Tumbled in November
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • AMRN

Shares of the cardiovascular disease specialist Amarin (NASDAQ: AMRN) lost approximately a quarter of their value during the month of November, according to data from S&P Global Market Intelligence. Rather, Amarin's stock appears to have simply followed the broader biotech space downward last month. Amarin's shares, in particular, were probably a victim of year-end tax-loss selling last month.